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Abstract 
    Background: The prevalence of metabolic syndrome (MS) is rapidly increasing in the world. Thus, the aim of the present study was 
to identify the latent subgroups of  Iranian male adults based on MS components and investigate the effect of abnormal alanine 
aminotransferase (ALT) and aspartate aminotransferase (AST), high total cholesterol (TC), and low-density lipoprotein  (LDL) on the 
odds of membership in each class. 
   Methods: In the present study, we used the data of a population-based screening program conducted on 823 urban adult men aged 25 
years and older in city of Qom in 2014.  Abdominal obesity, fasting blood sugar (FBS), blood pressure, and serum lipid profile were 
measured in participants after for at least 8 hours. MS was defined according to the Adults Treatment Panel III criteria. Latent class 
analysis was used to achieve the aims of study. Analyses were conducted using PROC LCA in SAS 9.2 software. In all analysis, p value 
< 0.05 was considered statistically significant. 
   Results: There were 3 different latent classes among participants. Latent class 1, non-MS, 55.1%; latent lass 2, at risk, 21.3%; and 
finally latent class 3, MS, with 23.6% of the participants. Age (OR=0.98, 95% CI: 0.98-0.99, high LDL (OR=0.27, 95% CI: 0.13-0.56), 
high TC (OR=8.12, 95% CI: 4.40-15.00), and abnormal ALT (OR=2.25, 95% CI 1.49-3.41) were associated with at risk class. Also, 
only age (OR=1.02, 95% CI: 1.01-1.04) was associated with MS class. The most prevalent components among the participants were 
having low HDL (34.0%) and high WC (33.9%). 
   Conclusion: Notable percent of samples fell in “at risk” and “MS” classes, which stress the necessity of designing preventive 
interventions for these specific stratums of population.  
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↑What is “already known” in this topic: 
The prevalence of metabolic syndrome (MS) is rapidly increasing in 
the world. In Iran, its prevalence has been reported to be 23.8% to 
36.9% in adults. Elevated ALT and AST may be risk factors for MS. 
There is limited information about the relationship of MS with 
NAFLD.   
 
→What this article adds: 
There were 3 different latent classes among participants of this study: 
Latent class 1, non-MS, 55.1%; latent lass 2, at risk, 21.3%; and latent 
class 3, MS, with 23.6% of the participants. This study showed that 
abnormal AST had no significant effect on the membership of adults 
in different classes. However, abnormal ALT increased the odds of 
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etc.  is rapidly increasing worldwide (1, 2).  
The cluster of metabolic factors for MS includes ab-
dominal obesity, high blood pressure, low HDL, high tri-
glyceride levels, impaired fasting glucose, and insulin re-
sistance (3, 4). There is evidence that MS greatly increases 
the risk of developing type 2 diabetes, heart diseases, and  
mortality rates (2, 5). According to the International Diabe-
tes Federation  (IDF) reports, about 20%-25% of the 
world’s adult population has MS. Individuals with MS have 
2 times greater risk of mortality, 3 times greater risk of heart 
attack and stroke, and 5 times greater risk of diabetes (6). 
Results of previous studies have shown high prevalence 
of MS in both Western and Asian countries (7-10). For ex-
ample, the prevalence of MS was reported to be 32.3%, 
33%, and 28.3% in England, India, and Saudi Arabia, re-
spectively (9-11).  
MS is a common condition in Iran and is associated with 
ethnicity, socioeconomic status, and diet. This syndrome 
can be diagnosed early in adolescence through measuring 
simple anthropometric indices (12). A number of studies 
conducted in Iran showed various prevalence of MS among 
adults ranging from 23.8% to 36.9%, which is relatively 
higher than the prevalence of MS among American adults 
(3, 13, 14). In a recent study, the overall prevalence of MS 
was estimated 23.0%, which was the highest in those 55 to 
64 years (38.6%) (15).   
Alanine aminotransferase (ALT) and aspartate ami-
notransferase (AST) are markers of nonalcoholic fatty liver 
disease (NAFLD) (16). NAFLD is a component of MS; 
thus, elevated ALT and AST may be risk factors for MS 
(17). There is limited information about the relationship of 
MS with NAFLD.  
The clinical definition of MS includes presence of 3 or 
more of its components. However, it does not matter that a 
person engages in which of the 3 components (18, 19). Un-
derstanding which MS components cooccur with each other 
is possible with subgrouping individuals based on  these 
components (20). Identifying quantitatively and qualita-
tively different subgroups of MS components is possible 
with latent class analysis (LCA) (21). Considering distinct 
profiles of MS can help physicians, health policymakers, 
and health service providers in applying true decisions in 
prevention programs (19, 20).  
The latent class analysis (LCA) is a structural equation 
model that divides individuals into distinct subgroups with 
respect to obvious variables. Since the probability of rela-
tionships between the components of MS is different in 
each subgroup, LCA may be useful in describing and iden-
tifying the characteristics of these individuals based on the 
components of MS. In Iran, a few number of studies applied 
this model to identify  the pattern of MS and its components 
(20). However, this method was never used in previous 
population-based studies among Iranian adults. Moreover, 
the effect of abnormal ALT and AST, high total cholesterol 
(TC), and high LDL on MS components was not evaluated 
in previous studies. Therefore, the present study aimed to 
evaluate the pattern of MS by identifying latent classes of 
MS among Iranian adults and investigate the effect of ab-
normal ALT and AST, high TC, and high LDL on the odds 
of membership in each class.  
Methods 
Participants 
In the present study, we used the data of a population-
based screening program that was conducted among 823 
urban adult men aged 25 years and older in city of Qom in 
2014. In this study, participants were selected using multi-
stage random sampling. First, the proportion of each district 
was calculated to select participants. Next, systematic ran-
som sampling was used to recruit participants in each stra-
tum. Participants were men aged at least 24 years who were 
living in Qom, Iran. More details are described in our recent 
published articles (15, 22). 
 
Measurements 
Data collection was designed in 2 stages. At the first 
stage, a self-repot health interview survey was adminis-
trated to evaluate participants’ self-report health status and 
to collect demographic information. In the second stage, 
based on the study protocol, all participants were invited to 
take part in screening. A serum lipid profile was ordered for 
all participants after no caloric intake for at least 8 hours 
and the laboratory results were assessed. This profile in-
cluded total cholesterol, high-density lipoprotein (HDL), 
low-density lipoprotein (LDL), cholesterol, very low-den-
sity lipoprotein (VLDL) cholesterol, triglyceride (TG), and 
hemoglobin tests.  
In the present study, MS was defined based on the ATP 
III (23) criteria. According to this criteria, the presence of 
3 or more of the following items considered as MS: (1) high 
blood pressure ((≥130/85 mmHg or a history of hyperten-
sion), (2) abdominal obesity (waist circumference > 102 
cm), (3) FBG ≥ 110 mg/dL (or a history of diabetes melli-
tus), (4) fasting HDL cholesterol < 40 mg/dL, and (5) fast-
ing TGs ≥ 150mg/dL.   The more details of measurements 
were described in our recent articles (15, 22).  
 
Ethical consideration 
All participants in the present study provided written in-
formed consent, and ethical committee of Qom University 
of Medical sciences approved the study protocol. 
   
Statistical analysis 
In this study, LCA was used for data analysis, which is 
appropriate for classifying the study participants into dif-
ferent categorical latent variables based on their homoge-
neity. This analysis assumes that the possible correlation of 
the indicator variables can be justified by latent variables 
categories by considering the measurement error. LCA de-
termines the best model with different iterations for the 
number of identified latent classes and comparing the fre-
quencies of the observed and expected response patterns. 
For each model, the LCA calculates G2 statistic. Also, 
Akaike information criterion (AIC) and Bayesian infor-
mation criterion (BIC) were calculated based on G2 to se-
lect the final model (24). For these indices, a smaller value 
shows a more optimal balance of model fit and parsimony. 
Finally, a model with the minimum value of AIC or BIC 
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Five binary indicator variables were selected to perform 
LCA, and 5 dichotomous observable variables (eg, indica-
tors) were used to subgroup the participants based on MS 
components as a latent variable. These indicators were high 
blood pressure (BP), abdominal obesity, fasting blood 
sugar (FBS), high-density lipoprotein (HDL), cholesterol, 
and triglyceride (TG). After finalizing the model, abnormal 
AST and ALT, high TC, high LDL, and age were entered 
as covariates in the model.  
Given the 5 binary variables, a total of 32 response pat-
terns were identified. Different measures of model assess-
ment are presented in Table 1. Since the degree of freedom 
of G2 statistic was less than 60 (G2 was distributed approx-
imately as chi-square), the overall significance of the esti-
mated model (Goodness-of-fit) was computed using G2 sta-
tistic. When this index is significant, it indicates a signifi-
cant difference between expected and observed frequencies 
and, subsequently, it indicates that the fitted model is not 
appropriate.  
The probability of a “No” response can be calculated by 
subtracting the item-response probabilities from 1. These 
probabilities form the basis for interpretation and labeling 
of latent classes. The larger conditional probabilities appear 
in bold font to highlight the overall pattern. Due to re-
strictions of doing complex latent class analysis in SAS 
software, all analysis was done without considering sam-
pling weights. All analyses were done using PROC LCA in 
SAS 9.2 software (SAS Institute Inc. Cary, NC, USA).  In 





This study was conducted among 823 participants. Find-
ings showed that the mean age of the participants was 
54.30±18.81 years. Also, 214 (26.0%) of the participants 
were single.  The prevalence of metabolic syndrome com-
ponents is demonstrated in Table 2. Accordingly, low HDL 
(34.0%) and high WC (33.9%) were the most prevalent 
components in the participants.  
Based on the results of Table 1, hence, 3, 4 and 5 class 
models were not significant. In the next stage, the best-fit-
ted model was selected based on G2, AIC, and BIC. The 
model with the lowest G2, AIC, and BIC values is suitable. 
According to these model selection indices and interpreta-
bility of the results of the model, we concluded that the 3 
latent class model was appropriate.  
The results of the 3-class model showed that the differ-
ence of expected and observed frequency of response pat-
tern was not statistically significant (G2=20.54, df=14, 
p=0.114). After selecting the final model, we entered age, 
total cholesterol, LDL, abnormal AST and ALT as covari-
ates in LCA model.  
Table 3 shows the results of LCA for the 3-class model. 
This table has 2 parts: latent class prevalence and item-re-
sponse probabilities. Latent class prevalence or the proba-
bility of the membership in each latent class is presented in 
the first section of Table 3.   
There are 3 different latent classes among participants. 
Latent class 1, non-MS, with 55.1% of the participants; la-
tent lass 2, at risk, with 21.3% of the participants; and fi-
nally latent class 3, MS, with 23.6% of participants (Table 
3).  
Table 1. Comparison of different LCA models based on model selection criteria  
Number of la-
tent class 
Number of parameters esti-
mated 
G2 df AIC BIC P Value Maximum  
log-likelihood 
1 5 313.01 26 323.01 346.57 < 0.00001 -2407.55 
2 11 77.49 20 99.49 151.33 < 0.00001 -2289.79 
3 17 20.54 14 54.54 134.66 0.114015 -2261.32 
4 23 8.48 8 54.48 162.88 0.388039 -2255.29 
5 29 4.33 2 62.33 199.00 0.11475 -2253.21 
Note: LCA=Latent class analysis, AIC=Akaike information criterion, BIC=Bayesian information criterion.  
 
Table 2. Percentages of metabolic syndrome (MS) components among Iranian male adults 
 Total (n=823) 
Items N % 95% CI 
High BP 227 27.6 25.5-30.6 
High abdominal obesity 279 33.9 30.7-37.1 
High FBS 166 20.2 17.6-23.1 
Low HDL 280 34.0 31.0-37.6 
High TG 204 24.8 22.0-28.0 
 
Table 3. The 4 Latent classes model of components of metabolic syndrome 
 Latent class 
 Non-MS At risk MS 
Latent class prevalence 0.551 0.213 0.236 
Item-response probabilities 
High BP 0.133 0.027 0.833 
High WC 0.139 0.284 0.856 
High FBS 0.092 0.135 0.522 
Low HDL 0.275 0.586 0.284 
High TG 0.005 0.805 0.319 
Note: the probability of don’t engaging in each components can be calculated by subtracting the item response probabilities shown above from 1.  






























    
    










 ]  
    




Med J Islam Repub Iran. 2020 (27 Jun); 34:69. 
 
4 
The conditional probabilities of positive response to hav-
ing MS components are demonstrated in the second section 
of Table 3.  The first class, named “non-MS,” included 
55.1% of the study participants and was characterized by 
individuals exhibiting low probability for having all MS 
components. The second class, at risk, included 21.3% of 
the participants and was characterized by persons who had 
high probability for having low HDL and high TG. The 
third class, MS, included 23.6% of the participants and was 
characterized by individuals exhibiting high probability of 
having high BP, WC, and FBS.  
The first row of Table 3 shows the probabilities of mem-
bership in each latent class. For example, latent class 1, 
Non-MS, included almost 55% of the participants and la-
tent class 3, MS, included 23.6% of the participants.  
Table 4 shows the odds ratios of membership in each la-
tent class. For simplicity of interpretation, the first class 
(non-MS) was considered as a reference class, and mem-
bership in latent classes 2 and 3 was calculated compared 
to latent class 1. This table indicates that having high LDL 
decreases the odds of membership in class 2 compared to 
class 1. Also, having high TC increases the odds of mem-
bership in class 2 compared to class 1. This table shows that 
having abnormal AST have no significant effect on mem-
bership of participants in different classes compared to the 
first class.   
 
Discussion 
In this study, we identified latent subgroups of adults 
based on metabolic syndrome components using LCA and 
we were able to detect 3 separate classes:  non-MS, at risk, 
and MS. The probability of engaging in each component of 
metabolic syndrome was low in the first class (non-MS). In 
the second class (at risk), however, the probability of hav-
ing high HDL and high TG was high. In latent class 3 (MS), 
the probability of having high blood pressure, high ab-
dominal obesity, and high FBS was high. There are 2 main 
groups of analysis in quantitative research: variable-cen-
tered and person-centered. Variable-centered analysis in-
cludes correlations, ANOVAs, path models, and regres-
sions, which only assess the relationship between variables. 
Person-centered analysis includes cluster analysis and la-
tent class analysis, which are used to investigate how vari-
ables are combined across individuals. Unlike variable-
centered analysis that determines how characteristics are 
related to each other, person-centered analysis investigates 
how these variables group within individuals. As a result, 
LCA (as a person-centered analysis) can facilitate targeting 
future intervention resources to subgroup of adults based 
on MS components that promise to show the maximum 
treatment response (25, 26).  
In this study, only 1 latent class (the third class) had high 
probability for at least 3 components of MS consistently. In 
other words, the prevalence of metabolic syndrome was es-
timated as nearly 24% with LCA. On the other hand, about 
21% of the participants were at risk for developing meta-
bolic syndrome (the second class). The third class (MS) 
may indicate a clinical pathway generating the observed 
features of metabolic syndrome. From prevention view, the 
policymakers should focus on blood pressure, abdominal 
obesity, and fast blood sugar for reducing the probability of 
engaging in cardiovascular diseases, type 2 diabetes, and 
other complications of metabolic syndrome. In the second 
class, low HDL and high TG cooccurred among 21% of the 
participants. Understanding how the metabolic syndrome 
components comorbid and cluster together in the latent 
classes 2 and 3 can help clinicians to interpret the patho-
physiology of metabolic syndrome. A similar study among 
Iranian adults showed that abdominal obesity had an im-
portant role in classifying the study samples (20). In the 
present study, we found that some variables have high 
probability only in 1 class. It seems that for prevention pro-
grams, all these variables should have same importance. 
Nonetheless, results indicated that interventions for reduc-
ing the prevalence of blood pressure, abdominal obesity, 
and fasting blood sugar should be in priority, because of the 
high prevalence of latent class 3 compared to class 2. The 
most important finding in LCA model was that among per-
sons in latent class 3, some components of metabolic syn-
drome (low HDL and high TG) did not play an influential 
role in classifying the participants. On the other hand, these 
factors have high probability in the second class. In other 
words, about 45% of the study sample engaged with 2 or 3 
components of MS. The participants of this study had dif-
ferent patterns of MS components. Nevertheless, based on 
the results of this study, it seems that integrated interven-
tional programs should be designed to reduce the preva-
lence of all components of MS.  
Only a few published studies used LCA to identify the 
latent classes of metabolic syndrome components. In addi-
tion, the researchers have used different criteria to specify 
subgroups. Also, the study samples were different among 
similar studies. 
Edward et al found 3 latent classes of metabolic syn-
dromes among nondiabetic individuals. They showed that 
only 1 latent class was strongly associated with all MS 
components. Moreover, they found another latent class that 
was associated with hyperglycemia and hypertension  (19).  
Another study indicated that among participants of the 
multiethnic study of atherosclerosis (MESA) participants, 
there were 3 latent classes of MS components. The authors 
named them as non-MS, low risk, and MS. They found that 
29.9% and 35.4% of females and males were in latent class, 
respectively (18).  
Table 4. Predictors of membership in latent classes of MS components pattern 
Predictors P value C1 C2 C3 
OR (95%CI) OR (95%CI) OR (95%CI) 
Age (year) <0.001 Reference 0.98 (0.96-0.99) 1.02 (1.01-1.04) 
High LDL 0.004 Reference 0.27 (0.13-0.56) 0.67 (0.33-1.37) 
High TC <0.001 Reference 8.12 (4.40-15.00) 1.76 (0.88-3.54) 
Abnormal AST 0.629 Reference 0.87 (0.54-1.40) 1.24 (0.79-2.04) 
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 Abbasi-Ghahramanloo et al identified 4 latent classes of 
MS in Iranian adults: (1) non-MS (38.4%), (2) low-risk 
(18.6%), (3) high-risk (24.2%), and (4) MS (18.7%).  In 
other words, in this study, about 19% of the participants had 
a low-risk and 24% a high-risk of developing MS (20). In 
comparison to Abbasi-Ghahramanloo et al study, our find-
ings indicated that 21.3% of the participants were at risk of 
MS and 23.6% were engaged with MS. The best reason for 
this difference could be related to gender of the partici-
pants. Our study focused on men only.   
Prior studies stated that triglyceride (TG) is an independ-
ent risk  factor in developing CVD (27). On the other hand, 
it proposed that increased TG production in the liver due to 
insulin resistance preferentially produces TG-rich very 
low-density lipoprotein = s (VLDL), which finally gener-
ates  small dense-LDL particles (28). The association of TG 
concentration and LDL has been shown in a variable-cen-
tered study (29). In the present person-centered study, the 
results showed that having high TG increases the odds of 
membership in the second class and having high LDL sig-
nificantly reduces the odds of membership in the second 
class (OR = 0.27, 95% CI = 0.13-0.56). In the second class, 
the probability of having low HDL is high too and the effect 
of high LDL is not related only to high TG.  
The present study indicated that having abnormal ALT 
increases the odds of membership in latent class 2 (OR = 
2.25, 95% CI = 1.49-3.41). ALT as a marker of liver injury 
have been associated with dyslipidemia, including triacyl-
glycerols and low HDL (30-33). Our study also showed that 
abnormal ALT had no significant effect on the third latent 
class. Previous findings indicated that the ALT level is as-
sociated with gender of the participants and body mass in-
dex in the general population (34). These 2 factors were not 
assessed in our study.  
In this study, we identified latent classes of MS among a 
sample of men who were living in Qom for the first time. 
However, as a limitation, it was not clear how many people 
were unaware of their status or were not treated. Also, we 
were unable to subgroup and compare clustering of the par-
ticipants in different demographic groups such as smokers 
versus nonsmokers and other relevant factors.    
  
Conclusion  
Our study showed the separated subgroups of MS com-
ponents among a sample of Iranian men. Results indicated 
that notable percent of samples fell in “at risk” and “MS” 
classes, which stress the necessity of designing preventive 
interventions with considering risk factors for these specific 
stratums of population.    
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